[64Cu]Cu-3

N/A

Report date: 2025/11/21 17:41:02

NME

Base Information

Drug Name[64Cu]Cu-3

Drug Alias Name[64Cu]Cu-3

ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Copper > 64Cu +[5]

Mechanisms of ActionPositron-emission tomography enhancersProgrammed death-ligand 1 modulators

TargetsProgrammed death-ligand 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHelmholtz-Zentrum Dresden-Rossendorf

China Registration ClassN/A

Develop Information

Active CompaniesHelmholtz-Zentrum Dresden-Rossendorf

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A